<DOC>
	<DOCNO>NCT01957306</DOCNO>
	<brief_summary>The primary goal study evaluate safety efficacy 12 week treatment 4 grams/day Dr. Tagliaferri 's Menopause Formula ( administer 2 gram PO BID ) reduce frequency menopausal vasomotor symptom among healthy , postmenopausal woman , age 40-65 , moderate severe hot flush .</brief_summary>
	<brief_title>Safety Efficacy Dr. Tagliaferri 's Menopause Formula</brief_title>
	<detailed_description />
	<mesh_term>Hot Flashes</mesh_term>
	<criteria>1 . Provide write informed consent . 2 . Postmenopausal woman age 4065 year . 3 . Postmenopausal define one follow criterion : 1 . 12 month spontaneous amenorrhea ; 2 . 6 month spontaneous amenorrhea serum FSH &gt; 30 mIU/ml ; 3 . 6 week surgical amenorrhea follow bilateral oophorectomy without hysterectomy ; 4. hysterectomy alone serum FSH &gt; 30 mIU/ml . 4 . During Screening , patient must report least 5 moderate severe hot flash per day 35 moderate severe hot flash per week . 5 . On Screening Hot Flush Diary , demonstrate compliance ( indicate fill diary `` time '' `` time '' ) least 4 7 day . 6 . Currently receive medical care health care provider . 1 . History malignancy , exception nonmelanoma skin cancer cervical cancer diagnose treatment completion 1 year prior screening ( i.e. , participant cervical cancer basal cell carcinoma diagnose fully treat 2 year prior screen , participant would eligible study ) . 2 . Known carrier BRCA1 BRCA2 . 3 . Within 12 month screen , abnormal mammogram breast examination suggestive cancer , refuse mammogram breast exam . 4 . Within 12 month screen , abnormal Pap smear pelvic examination suggestive cancer , refuse Pap smear pelvic exam . 5 . Transvaginal Ultrasound ( TVUS ) doublewall endometrium &gt; 8mm TVUS . 6 . Participants polyps abnormal uterine mass ( exception fibroid ) TVUS . 7 . Unexplained uterine bleeding within six month prior screen . 8 . Clinical evidence active ischemic cardiovascular disease history cardiovascular disease . 9 . Uncontrolled hypertension ( â‰¥160/100 baseline within 4 week prior screen ) history transient ischemic attack cerebrovascular accident . 10 . History deep vein thrombosis pulmonary embolism . 11 . Active liver disease history impaired hepatic function . 12 . History chronic hepatitis B C , hepatitis within past 3 month , HIV infection . 13 . History severe chronic diarrhea , chronic constipation , uncontrolled irritable bowel syndrome ( IBS ) , uncontrolled inflammatory bowel disease ( IBD ) , unexplained weight loss . 14 . Active gallbladder disease . 15 . Use prescription medication know possibly effective treatment hot flush within : 1 week prior screen vaginal hormonal product ( ring , cream , gel ) , 4 week prior screen transdermal estrogen alone estrogen/progestin product , 4 week prior screen testosterone product ( oral , patch , gel cream ) , 8 week prior screen oral estrogen and/or progestin therapy intrauterine progestin therapy , 3 month prior screen progestin implant estrogen alone injectable drug therapy 6 month prior screen estrogen pellet therapy progestin injectable drug therapy . 16 . Use herbal dietary supplement purport treat hot flush herbal/dietary supplement know estrogenic progestogenic activity within 2 week screen . 17 . Use herbal dietary supplement within 2 week prior screen , unless participant agrees change frequency dose herbal supplement entire duration study treatment . 18 . Currently take morphine opiates chronic basis . 19 . Any laboratory finding normal range deem clinically significant . 20 . BMI &gt; 35 kg/m2 21 . History substance abuse within past year . 22 . Use another investigational agent within 1 month prior screen . 23 . History severe food medicine allergy result anaphylactic shock , require hospitalization , require use epinephrine . 24 . Any concern medical , emotional psychiatric condition , investigator 's opinion , would preclude participant providing informed consent , complete questionnaire , adhere protocol complete trial ( e.g. , severe illness , plan move , substance abuse , significant psychiatric problem , dementia ) .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>hot flash , night sweat</keyword>
</DOC>